Russell Investments Group, Ltd. Aeterna Zentaris Inc. Transaction History

Russell Investments Group, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$1.0 - $2.97 $7,917 - $23,513	-7,917 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.04 - $5.43 $2,927 - $7,792	-1,435 Reduced 15.34%	7,917 $23,000
Q1 2019 May 13, 2019	BUY	$3.03 - $4.65 $28,336 - $43,486	9,352 New	9,352 $43,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.